Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02838628 · ClinicalTrials.gov registry record · Phase 2
Activity & Safety Study of KX2-391 Ointment in Participants With Actinic Keratosis on the Face or Scalp
A Phase 2 study, sponsored by Almirall, S.A..
- Completed
- Registry status
- Phase 2
- Development phase
- 168
- Enrollment target
NCT02838628: Completed Phase 2 study, sponsored by Almirall, S.A..
NCT02838628 is a Phase 2 study that has completed, run by Almirall, S.A.. The registered enrollment target is 168 participants, above the 133-participant average among 30,622 other Phase 2 trials with a reported enrollment target (26% higher). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT02838628, a Phase 2 study, has completed, sponsored by Almirall, S.A..
- COMPLETED
- Registry status
- Phase 2
- Development phase
- 168 participants
- Enrollment target
Study Summary
In this study, the activity, safety, and pharmacokinetics (PK) of KX2-391 Ointment was evaluated in adult participants with a clinical diagnosis of stable, clinically typical actinic keratosis (AK) on the face or scalp.
Primary Outcome
Complete response rate was defined as the percentage of participants achieving 100% clearance in the treatment area on the face or scalp at Day 57.
Interventions
- DRUG 50 mg of KX2-391 Ointment 1%
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 168 participants |
| Start Date | 2016-04-11 |
| Est. Completion | 2017-12-22 |
| Phase | Phase 2 |
What the finished NCT02838628 record still lists
NCT02838628 is an interventional study that assigns participants to a tested intervention. The registered 168 participants enrollment target is mid-sized for trials with a published cap, above the 133-participant average among 30,622 other Phase 2 trials with a reported enrollment target (26% higher).
The record links to 0 conditions, and to 1 intervention - of which 50 mg of KX2-391 Ointment 1% is the first listed.
NCT02838628 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT02838628 about?
NCT02838628 is a clinical study titled "Activity & Safety Study of KX2-391 Ointment in Participants With Actinic Keratosis on the Face or Scalp". In this study, the activity, safety, and pharmacokinetics (PK) of KX2-391 Ointment was evaluated in adult participants with a clinical diagnosis of stable, clinically typical actinic keratosis (AK) on the face or scalp.
What is the current status of trial NCT02838628?
This trial is currently completed. It is a Phase 2 study. The enrollment target is 168 participants. The study started on 2016-04-11. Estimated completion is 2017-12-22.
What interventions are being tested in trial NCT02838628?
The interventions under investigation include: 50 mg of KX2-391 Ointment 1% (DRUG).
Who is sponsoring clinical trial NCT02838628?
This trial is sponsored by Almirall, S.A., which has 19 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT02838628's enrollment target sits among peer trials
168 403rd of 2000 higher than 1,595 of 2,000 other Phase 2 trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Phase 2 trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT02118922 · 168 participants
A Study to Test the Diagnostic Potential of Brillouin Microscopy for Corneal Ectasia
- NCT03536897 · 168 participants
IORT Following Breast Conserving Surgery for Early Stage Breast Cancer Registry
- NCT04078230 · 168 participants · NA
Regional or Extend LymphAdenectomy During Resection of Intrahepatic Cholangiocarcinoma
- NCT04159168 · 168 participants · NA
Facial Affect Sensitivity Training for Young Children With Callous-unemotional Traits
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI